7-chloro-N-(pyridin-2-yl)quinolin-4-amine | 92161-76-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 7-chloro-N-(pyridin-2-yl)quinolin-4-amine
• 英文别名: 4-<2>Pyridylamino-7-chlor-chinolin；(7-chloro-quinolin-4-yl)-pyridin-2-yl-amine；7-chloro-N-pyridin-2-ylquinolin-4-amine
• CAS: 92161-76-7
• 化学式: C₁₄H₁₀ClN₃
• 分子量: 255.707
• InChiKey: PPIODDGHOWHPKY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  37.8
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• [EN] QUINONE REDUCTASE 2 INHIBITORS FOR USE AS NEUROPROTECTIVE AGENTS<br/>[FR] INHIBITEURS DE LA QUINONE RÉDUCTASE 2 DESTINÉS À ÊTRE UTILISÉS EN TANT QU'AGENTS NEUROPROTECTEURS
  申请人：UNIV DUKE

  公开号：WO2020081678A1

  公开（公告）日：2020-04-23

  Provided herein according to some embodiments is a method of treating acute neural injury in a subject in need thereof, comprising administering to the subject a compound of Formula I or Formula II. Also provided is a method of treating vascular dementia in a subject in need thereof, comprising administering to the subject a compound of Formula I or Formula II. Further provided is a method of treating CNS lupus in a subject in need thereof, comprising administering to the subject a compound of Formula I or Formula II.

  根据某些实施例所提供的是一种治疗急性神经损伤的方法，包括向需要的受试者施用化合物I或化合物II。还提供了一种治疗血管性痴呆的方法，包括向需要的受试者施用化合物I或化合物II。此外，还提供了一种治疗中枢神经系统红斑狼疮的方法，包括向需要的受试者施用化合物I或化合物II。
• Compounds for preventing, inhibiting, or treating cancer, aids and/or premature aging
  申请人：ABIVAX

  公开号：US10683284B2

  公开（公告）日：2020-06-16

  The manufacture and use of compounds of formula (Ia) or a pharmaceutically acceptable salt thereof for preventing, inhibiting or treating cancer, AIDS and/or premature aging. The compounds of formula (Ia) being: where: R independently represents a hydrogen atom, a halogen atom, a (C1-C3)alkyl group, a —CN group, a hydroxyl group, a —COOR1 group, a (C1-C3)fluoroalkyl group, a —NO2 group, a —NR1R2 group, or a (C1-C3)alkoxy group; R′ is a hydrogen atom, a halogen atom, a (C1-C3)alkyl group, a —NO2 group, a (C1-C3)alkoxy group, or a —NR1R2 group; and R1 and R2 are a hydrogen atom or a (C1-C3) alkyl group.

  式（Ia）化合物或其药学上可接受的盐的制造和使用，用于预防、抑制或治疗癌症、艾滋病和/或早衰。式 (Ia)化合物为： 其中 R 独立地代表氢原子、卤素原子、(C1-C3)烷基、-CN 基团、羟基、-COOR1 基团、(C1-C3)氟烷基、-NO2 基团、-NR1R2 基团或(C1-C3)烷氧基； R′ 是氢原子、卤素原子、(C1-C3)烷基、- 基团、(C1-C3)烷氧基或 -NR1R2 基团；以及 R1 和 R2 是氢原子或 (C1-C3) 烷基。
• QUINONE REDUCTASE 2 INHIBITORS FOR USE AS NEUROPROTECTIVE AGENTS
  申请人：DUKE UNIVERSITY

  公开号：US20210393614A1

  公开（公告）日：2021-12-23

  Provided herein according to some embodiments is a method of treating acute neural injury in a subject in need thereof, comprising administering to the subject a compound of Formula I or Formula II. Also provided is a method of treating vascular dementia in a subject in need thereof, comprising administering to the subject a compound of Formula I or Formula II. Further provided is a method of treating CNS lupus in a subject in need thereof, comprising administering to the subject a compound of Formula I or Formula II.
• COMPOUNDS FOR PREVENTING, INHIBITING, OR TREATING CANCER, AIDS AND/OR PREMATURE AGING
  申请人：ABIVAX

  公开号：US20220127253A1

  公开（公告）日：2022-04-28

  The manufacture and use of compounds of formula (Ia) or a pharmaceutically acceptable salt thereof for preventing, inhibiting or treating cancer, AIDS and/or premature aging. The compounds of formula (Ia) being: where: R independently represents a hydrogen atom, a halogen atom, a (C 1 -C 3 )alkyl group, a —CN group, a hydroxyl group, a —COOR 1 group, a (C 1 -C 3 )fluoroalkyl group, a —NO 2 group, a —NR 1 R 2 group, or a (C 1 -C 3 )alkoxy group; R′ is a hydrogen atom, a halogen atom, a (C 1 -C 3 )alkyl group, a —NO 2 group, a (C 1 -C 3 )alkoxy group, or a —NR 1 R 2 group; and R 1 and R 2 are a hydrogen atom or a (C 1 -C 3 ) alkyl group.